Latest News
China makes great efforts to contain COVID-19, saves more lives: SCO Secretary-General
WUHAN, China, June 4, 2021 /PRNewswire/ -- China has made great efforts to contain the spread of COVID-19 and saved more lives, Secretary-General of the Shanghai Cooperation Organization (SCO) Vladimir Norov told Global Times Online on the sidelines of the SCO non-governmental friendship forum he...
2021-06-07 11:35
1949
Online Premium Brands Flash Sale Platform - SHOPPICKS Is Officially Opened
HONG KONG, June 7, 2021 /PRNewswire/ -- Online shopping makes life much easier, especially under the COVID-19 pandemic. In times when online shopping has gone viral across the world, here comes SHOPPICKS - an online fashion flash sale platform. SHOPPICKS brings in a new online shopping format by ...
2021-06-07 11:00
3325
Igor Sechin Presents Keynote Speech at SPIEF's Global Energy Transformation Panel
MOSCOW, June 7, 2021 /PRNewswire/ -- Igor Sechin, Chief Executive Officer of Rosneft, delivered a keynote speech at the Energy Panel "Transformation of the Global Energy Sector" at the XXIV St. Petersburg International Economic Forum. The event, sponsored by Rosneft, was attended by BP CEO Bernar...
2021-06-07 11:00
2643
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Plus Paclitaxel/Cisplatin for the First-line Treatment of ESCC at ASCO 2021
SUZHOU, China, June 7, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced data from Phase 2 clinical study (KN046-204) of KN046(PD-L1/CTLA-4 bispecific antibody) plus paclitaxel/cisplatin for the first-line treatment of unresectable locally advanced, recurrent or metastatic e...
2021-06-07 10:11
7087
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021
* KN046 combined with platinum doublet chemotherapy is tolerated and has shown promising clinical benefit as IL treatment for stage IV NSCLC. * OS rate at 12 months and 15 months were both 74.9%; Similar survival was observed in patients with PD-L1≥1% and PD-L1<1%; * the median progression-f...
2021-06-07 10:10
6561
Tonik becomes PH's first neobank to secure digital bank license
MANILA, Philippines, June 7, 2021 /PRNewswire/ -- Tonik, the Philippines' first digital-only neobank continues to make waves in the local fintech and banking industry as it secures a digital bank license from the Bangko Sentral ng Pilipinas (BSP) – the first for any private and purely digital ba...
2021-06-07 10:00
3065
OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting
SHANGHAI, June 7, 2021 /PRNewswire/ -- On June 4, 2021 (EST), OriginCell Therapeutics (Shanghai) Co., Ltd. ("OriginCell"), together with Lishui Central Hospital affiliated toZhejiang University and Shanghai Changzheng Hospital, presented the updated data from the on-going trial of Ori-CAR-001,...
2021-06-07 10:00
4390
Hyperice Named Official Recovery Technology Partner by League of Legends Pro League
SHANGHAI, June 7, 2021 /PRNewswire/ -- League of Legends Pro League (LPL) and Hyperice, the industry leader in recovery technology and pioneer of percussion, vibration, dynamic air compression and thermal technology, today announced a partnership that names Hyperice the league's Official Recovery...
2021-06-07 10:00
3701
America's Fastest Growing Company Joined Australia in Alleviating the IT Talent Shortfall
HO CHI MINH CITY, Vietnam, June 7, 2021 /PRNewswire/ -- KMS Solutions has officially entered the Australian market after seeing more local enterprises reached out for its software engineering and digital team services. To ease the IT talent shortage that is plaguing Australia, KMS Solutions anno...
2021-06-07 10:00
3245
BIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June
PORTO, Portugal, June 7, 2021 /PRNewswire/ -- The second edition of the BIAL Award in Biomedicine is currently underway. Worth three hundred thousand Euros, this prize is intended to reward a work with exceptional quality results and scientific relevance published in the last ten years in the bro...
2021-06-07 10:00
1741
Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021
* As of January 15, 2021, 9 patients were included in the efficacy analysis and 17 patients in the safety analysis. ORR was 55.6%, and DCR was 88.9%. * The updated results from this Phase II study will be presented at an upcoming medical meeting. A phase III clinical study of KN046 in combinat...
2021-06-07 09:53
6544
CSOP Asset Management Ltd. Chooses SS&C to Support Operations
WINDSOR, Conn., June 7, 2021 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced thatHong Kong's CSOP Asset Management Ltd. has selected Eze Investment Suite for order management and portfolio accounting. Eze Investment Suite provides the flexibility CSOP required for ...
2021-06-07 09:00
11106
Trip.com Group joins the United Nations Global Compact
SINGAPORE, June 7, 2021 /PRNewswire/ -- Trip.com Group, leading global travel services provider, has joined the United Nations Global Compact to inspire change. Since 17th May 2021, Trip.com Group has been committed to the UN Global Compact corporate responsibility initiative and its principles i...
2021-06-07 09:00
3617
BenQ Launches World's First 4K HDR 16ms Gaming Projector, Cements No.1 Market Share in 4K Projector Segment
SINGAPORE, June 7, 2021 /PRNewswire/ -- BenQ, the global No.1 DLP projector brand, today launched a brand-new gaming projector segment with the new TK700STi 4K Gaming Projector, bringing users the unprecedented combination of 4K resolution at 16ms low input lag for a premium all-in-one entertainme...
2021-06-07 09:00
2945
WeBank and SMU Nurture Future-Ready Fintech Talent with Blockchain Courses
SHENZHEN, China, June 7, 2021 /PRNewswire/ -- WeBank, the world's leading digital bank and the first digital-only bank inChina, announced that its summer enrichment programme onFISCO BCOS[1] Blockchain Experience at the Singapore Management University (SMU), a premier university in Asia internati...
2021-06-07 09:00
4117
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication
HANGZHOU, China and SHAOXING, China, June 7, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its drug candidate ASC42 to conduct clinical trials for ch...
2021-06-07 08:30
3888
Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-07 08:00
8493
Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-07 08:00
8560
Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting
SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-07 08:00
8480
Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-07 08:00
8404
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 312 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 304 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 302 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
